These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8614520)

  • 1. Manganese intoxication in the rhesus monkey: a clinical, imaging, pathologic, and biochemical study.
    Olanow CW; Good PF; Shinotoh H; Hewitt KA; Vingerhoets F; Snow BJ; Beal MF; Calne DB; Perl DP
    Neurology; 1996 Feb; 46(2):492-8. PubMed ID: 8614520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI and PET studies of manganese-intoxicated monkeys.
    Shinotoh H; Snow BJ; Hewitt KA; Pate BD; Doudet D; Nugent R; Perl DP; Olanow W; Calne DB
    Neurology; 1995 Jun; 45(6):1199-204. PubMed ID: 7783889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of manganese inhalation on basal ganglia dopamine concentrations in rhesus monkey.
    Bird ED; Anton AH; Bullock B
    Neurotoxicology; 1984; 5(1):59-65. PubMed ID: 6538950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnosis of manganese-induced parkinsonism.
    Cersosimo MG; Koller WC
    Neurotoxicology; 2006 May; 27(3):340-6. PubMed ID: 16325915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPTP-Induced pallidal lesions in rhesus monkeys.
    Zhang Z; Zhang M; Ai Y; Avison C; Gash DM
    Exp Neurol; 1999 Jan; 155(1):140-9. PubMed ID: 9918713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Exp Neurol; 2000 May; 163(1):191-9. PubMed ID: 10785458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From manganism to manganese-induced parkinsonism: a conceptual model based on the evolution of exposure.
    Lucchini RG; Martin CJ; Doney BC
    Neuromolecular Med; 2009; 11(4):311-21. PubMed ID: 20012385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic MRI (phMRI) as a tool to differentiate Parkinson's disease-related from age-related changes in basal ganglia function.
    Andersen AH; Hardy PA; Forman E; Gerhardt GA; Gash DM; Grondin RC; Zhang Z
    Neurobiol Aging; 2015 Feb; 36(2):1174-82. PubMed ID: 25443764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.
    Wichmann T; Kliem MA; DeLong MR
    Exp Neurol; 2001 Feb; 167(2):410-24. PubMed ID: 11161630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship among nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model.
    Di Monte DA; McCormack A; Petzinger G; Janson AM; Quik M; Langston WJ
    Mov Disord; 2000 May; 15(3):459-66. PubMed ID: 10830409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of manganese-associated neurotoxicity.
    Racette BA; Aschner M; Guilarte TR; Dydak U; Criswell SR; Zheng W
    Neurotoxicology; 2012 Aug; 33(4):881-6. PubMed ID: 22202748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurons in the globus pallidus do not show correlated activity in the normal monkey, but phase-locked oscillations appear in the MPTP model of parkinsonism.
    Nini A; Feingold A; Slovin H; Bergman H
    J Neurophysiol; 1995 Oct; 74(4):1800-5. PubMed ID: 8989416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinsonism caused by chronic usage of intravenous potassium permanganate.
    Meral H; Kutukcu Y; Atmaca B; Ozer F; Hamamcioglu K
    Neurologist; 2007 Mar; 13(2):92-4. PubMed ID: 17351530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)-induced hemiparkinsonism on the kinematics of a two-dimensional,multijoint arm movement in the rhesus monkey.
    Camarata PJ; Parker RG; Park SK; Haines SJ; Turner DA; Chae H; Ebner TJ
    Neuroscience; 1992; 48(3):607-19. PubMed ID: 1351272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modeling parkinsonism (review)].
    Atadzhanov M
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):110-9. PubMed ID: 6805182
    [No Abstract]   [Full Text] [Related]  

  • 17. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropathology of manganese-induced Parkinsonism.
    Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):675-82. PubMed ID: 17882011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rest tremor in rhesus monkeys with MPTP-induced parkinsonism.
    Emborg ME; Tetrud JW; Moirano J; McLaughlin WW; Bankiewicz KS
    Front Biosci; 2003 May; 8():a148-54. PubMed ID: 12700090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.
    Blandini F; Levandis G; Bazzini E; Nappi G; Armentero MT
    Eur J Neurosci; 2007 Jan; 25(2):397-405. PubMed ID: 17284180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.